<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Respir Crit Care Med</journal-id><journal-id journal-id-type="iso-abbrev">Am J Respir Crit Care Med</journal-id><journal-id journal-id-type="pmc-domain-id">465</journal-id><journal-id journal-id-type="pmc-domain">ajrccm</journal-id><journal-id journal-id-type="publisher-id">ajrccm</journal-id><journal-title-group><journal-title>American Journal of Respiratory and Critical Care Medicine</journal-title></journal-title-group><issn pub-type="ppub">1073-449X</issn><issn pub-type="epub">1535-4970</issn><publisher><publisher-name>American Thoracic Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10515575</article-id><article-id pub-id-type="pmcid-ver">PMC10515575.1</article-id><article-id pub-id-type="pmcaid">10515575</article-id><article-id pub-id-type="pmcaiid">10515575</article-id><article-id pub-id-type="pmid">37534937</article-id><article-id pub-id-type="doi">10.1164/rccm.202302-0271OC</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject><subj-group><subject>Interstitial Lung Disease</subject></subj-group></subj-group></article-categories><title-group><article-title>Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9249-0542</contrib-id><name name-style="western"><surname>Grant-Orser</surname><given-names initials="A">Amanda</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Min</surname><given-names initials="B">Bohyung</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Elmrayed</surname><given-names initials="S">Seham</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9559-1485</contrib-id><name name-style="western"><surname>Podolanczuk</surname><given-names initials="AJ">Anna J.</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1205-5511</contrib-id><name name-style="western"><surname>Johannson</surname><given-names initials="KA">Kerri A.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><aff id="aff1"><label><sup>1</sup></label>Division of Respirology, Department of Medicine,</aff><aff id="aff2"><label><sup>2</sup></label>Department of Community Health Sciences, and</aff><aff id="aff3"><label><sup>3</sup></label>Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada;</aff><aff id="aff4"><label><sup>4</sup></label>The American University in Cairo, Cairo, Egypt; and</aff><aff id="aff5"><label><sup>5</sup></label>Division of Pulmonary and Critical Care, Department of Medicine, Weill Cornell Medical Center, New York, New York</aff></contrib-group><author-notes><corresp>Correspondence and requests for reprints should be addressed to Amanda Grant-Orser, M.B. B.Ch., F.R.C.P.C., Division of Respirology, Department of Medicine, University of Calgary, 6th Floor &#8211; Pulmonary Diagnostics, 4448 Front Street S.E., Calgary, AB, T3M-1M4 Canada. E-mail: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:amanda.grant-orser@mail.mcgill.ca">amanda.grant-orser@mail.mcgill.ca</email>.</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>3</day><month>8</month><year>2023</year></pub-date><pub-date date-type="collection" publication-format="electronic"><day>15</day><month>9</month><year>2023</year></pub-date><volume>208</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">445824</issue-id><fpage>695</fpage><lpage>708</lpage><history><date date-type="received"><day>14</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>2</day><month>8</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>15</day><month>09</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>15</day><month>09</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-15 00:25:13.833"><day>15</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 by the American Thoracic Society</copyright-statement><copyright-year>2023</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="rccm.202302-0271OC.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="rccm.202302-0271OC.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" xml:lang="en" xlink:title="editorial" journal-id="Am J Respir Crit Care Med" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC10515573"><article-title>Adult Interstitial Lung Abnormalities: The New Frontier of Pulmonary Fibrosis</article-title><volume>208</volume><issue>6</issue><date><day>8</day><month>8</month><year>2023</year></date><fpage>651</fpage><lpage>652</lpage><source>American Journal of Respiratory and Critical Care Medicine</source><pub-id pub-id-type="doi">10.1164/rccm.202307-1287ED</pub-id><pub-id pub-id-type="pmcid">PMC10515573</pub-id><pub-id pub-id-type="pmid">37552023</pub-id></related-article><abstract><sec><title>Rationale</title><p>Incidental parenchymal abnormalities detected on chest computed tomography scans are termed interstitial lung abnormalities (ILAs). ILAs may represent early interstitial lung disease (ILD) and are associated with an increased risk of progressive fibrosis and mortality. The prevalence of ILAs is unknown, with heterogeneity across study populations.</p></sec><sec><title>Objectives</title><p>Estimate the pooled prevalence of ILAs in lung cancer screening, general population-based, and at-risk familial cohorts using meta-analysis; identify variables associated with ILA risk; and characterize ILA-associated mortality.</p></sec><sec><title>Methods</title><p>The study protocol was registered on PROSPERO (CRD42022373203), and Meta-analyses of Observational Studies in Epidemiology recommendations were followed. Relevant studies were searched on Embase and Medline. Study titles were screened and abstracts reviewed for full-text eligibility. Random effect models were used to pool prevalence estimates for specified subgroups and ILA-associated mortality risk. Risk of ILAs was estimated based on age, sex, and FVC. Quality assessment was conducted using an adapted Assessment Tool for Prevalence Studies.</p></sec><sec><title>Measurements and Main Results</title><p>The search identified 9,536 studies, with 22 included, comprising 88,325 participants. The pooled ILA prevalence was 7% (95% confidence interval [CI], 0.01&#8211;0.13) in lung cancer screening, 7% (95% CI, 0.04&#8211;0.10) in general population, and 26% (95% CI, 0.20&#8211;0.32) in familial cohorts. Pooled mortality risk was increased in those with ILAs (odds ratio, 3.56; 95% CI, 2.19&#8211;5.81). Older age, male sex, and lower FVC% were associated with greater odds of ILA.</p></sec><sec><title>Conclusions</title><p>Populations undergoing imaging for non-ILD indications demonstrate high ILA prevalence. Standardized reporting and follow-up of ILAs is needed, including defining those at greatest risk of progression to ILD.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>ILAs</kwd><kwd>interstitial lung disease</kwd><kwd>lung cancer screening</kwd><kwd>familial pulmonary fibrosis</kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant"><funding-source country="US"><institution>NHLBI</institution></funding-source><award-id>K23HL140199</award-id></award-group></funding-group><counts><fig-count count="4"/><table-count count="2"/><ref-count count="51"/><page-count count="14"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>